Eiman Ibrahim

494 total citations
17 papers, 270 citations indexed

About

Eiman Ibrahim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Eiman Ibrahim has authored 17 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Genetics. Recurrent topics in Eiman Ibrahim's work include Cancer Immunotherapy and Biomarkers (5 papers), Glioma Diagnosis and Treatment (3 papers) and Cancer-related cognitive impairment studies (2 papers). Eiman Ibrahim is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Glioma Diagnosis and Treatment (3 papers) and Cancer-related cognitive impairment studies (2 papers). Eiman Ibrahim collaborates with scholars based in United States, Poland and France. Eiman Ibrahim's co-authors include Barbara E. Ehrlich, Naifa L. Busaidy, Brenda Cartmel, Sarah S. Mougalian, Mohamed Elfil, Kate Nyhan, Maria E. Cabanillas, Scott Kopetz, Steven I. Sherman and Angelica M. Silva and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Eiman Ibrahim

15 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiman Ibrahim United States 7 172 65 46 39 36 17 270
Udo Schnitzbauer Switzerland 11 53 0.3× 46 0.7× 187 4.1× 19 0.5× 185 5.1× 17 396
A. Bertolini Italy 10 112 0.7× 73 1.1× 112 2.4× 6 0.2× 7 0.2× 37 310
J.C. Dumon Belgium 12 273 1.6× 72 1.1× 80 1.7× 4 0.1× 46 1.3× 18 360
Omotayo Arowojolu United States 9 39 0.2× 60 0.9× 113 2.5× 9 0.2× 19 0.5× 11 358
Debra M. Prow United States 9 103 0.6× 47 0.7× 41 0.9× 3 0.1× 8 0.2× 13 265
Grace Hsieh United States 8 102 0.6× 18 0.3× 237 5.2× 5 0.1× 87 2.4× 11 463
Marta Dratwa Poland 11 60 0.3× 39 0.6× 164 3.6× 4 0.1× 37 1.0× 19 449
Inmaculada Catalina‐Fernández Spain 11 99 0.6× 23 0.4× 96 2.1× 22 0.6× 4 0.1× 16 330
Renzo Lazzarini Italy 9 138 0.8× 29 0.4× 86 1.9× 12 0.3× 2 0.1× 11 333
Karen van der Weide Netherlands 8 56 0.3× 16 0.2× 117 2.5× 4 0.1× 17 0.5× 11 324

Countries citing papers authored by Eiman Ibrahim

Since Specialization
Citations

This map shows the geographic impact of Eiman Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiman Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiman Ibrahim more than expected).

Fields of papers citing papers by Eiman Ibrahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiman Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiman Ibrahim. The network helps show where Eiman Ibrahim may publish in the future.

Co-authorship network of co-authors of Eiman Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Eiman Ibrahim. A scholar is included among the top collaborators of Eiman Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiman Ibrahim. Eiman Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lin, Derrick T., Anthos Christofides, Etienne Léveillé, et al.. (2024). Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohort. Cardio-Oncology. 10(1). 84–84. 5 indexed citations
2.
3.
4.
Ibrahim, Eiman & Ricardo Correa. (2022). Diagnostic Value of Preoperative Serum Calcitonin Levels in Medullary Thyroid Carcinoma. Clinical Thyroidology. 34(2). 85–88. 1 indexed citations
5.
Blenman, Kim, Malini Harigopal, Emily Reisenbichler, et al.. (2022). PD-L1 protein expression in relation to recurrence score values in early-stage ER + breast cancer. Breast Cancer Research and Treatment. 196(1). 221–227. 3 indexed citations
6.
Ibrahim, Eiman, et al.. (2022). Hope, Cure, and Adverse Effects in Immunotherapy: Atezolizumab-Associated Encephalitis in Metastatic Small Cell Lung Cancer – A Case Report and Literature Review. SHILAP Revista de lepidopterología. 14(3). 366–371. 1 indexed citations
7.
Marczyk, Michał, Tao Qing, Tess A. O’Meara, et al.. (2022). Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer. npj Breast Cancer. 8(1). 88–88. 9 indexed citations
8.
Ibrahim, Eiman, et al.. (2022). A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy. PLoS ONE. 17(10). e0275648–e0275648. 8 indexed citations
9.
Ibrahim, Eiman, et al.. (2022). A rare case of pituicytoma-related hypercortisolism in a patient with Cushing syndrome—case report. SHILAP Revista de lepidopterología. 46(1). 1 indexed citations
10.
Ibrahim, Eiman, et al.. (2021). The Impact of Mutations in Wolframin on Psychiatric Disorders. Frontiers in Pediatrics. 9. 718132–718132. 6 indexed citations
11.
Ibrahim, Eiman, Kate Nyhan, Mohamed Elfil, et al.. (2021). Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis. Frontiers in Oncology. 11. 642382–642382. 34 indexed citations
12.
Yaghoobi, Vesal, Myrto Moutafi, Thazin Nwe Aung, et al.. (2021). Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case–control study. Breast Cancer Research. 23(1). 113–113. 6 indexed citations
13.
Jones, Beth A., et al.. (2020). Abstract PO-263: COVID-19 and social determinants of health (SDOH): Impact on cancer prevention in vulnerable populations. Cancer Epidemiology Biomarkers & Prevention. 29(12_Supplement). PO–263. 1 indexed citations
14.
Ibrahim, Eiman & Barbara E. Ehrlich. (2019). Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings. Critical Reviews in Oncology/Hematology. 145. 102831–102831. 118 indexed citations
15.
Nguyen, Há Thi, Callisia N. Clarke, Angelica M. Silva, et al.. (2019). Genetic profiling as a clinical tool in advanced parathyroid carcinoma. Journal of Cancer Research and Clinical Oncology. 145(8). 1977–1986. 38 indexed citations
16.
Hurvitz, Sara A., Arlene Chan, Nicholas Iannotti, et al.. (2018). Abstract P3-14-01: Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients with HER2+ early-stage breast cancer: The CONTROL trial. Cancer Research. 78(4_Supplement). P3–14. 11 indexed citations
17.
Ibrahim, Eiman & Naifa L. Busaidy. (2017). Treatment and surveillance of advanced, metastatic iodine-resistant differentiated thyroid cancer. Current Opinion in Oncology. 29(2). 151–158. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Udo Schnitzbauer Breakdown of academic impact, for papers by A. Bertolini Breakdown of academic impact, for papers by J.C. Dumon Breakdown of academic impact, for papers by Omotayo Arowojolu Breakdown of academic impact, for papers by Debra M. Prow Breakdown of academic impact, for papers by Grace Hsieh Breakdown of academic impact, for papers by Marta Dratwa Breakdown of academic impact, for papers by Inmaculada Catalina‐Fernández Breakdown of academic impact, for papers by Renzo Lazzarini Breakdown of academic impact, for papers by Karen van der Weide
Rankless by CCL
2026